YOLUP-H
MRP: 950
Packaging: 10x10
Pack Type: tablet
Composition:
Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg
Indication:
Essential Hypertension, Congestive Heart Failure, Proteinuria, High Risk Patients.
Description:
Olmesartan Medoxomil 20mg + Hydrochlorothiazide 12.5mg is a combination medication used to treat hypertension (high blood pressure). Olmesartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels to lower blood pressure, while Hydrochlorothiazide is a thiazide diuretic that helps reduce excess fluid by increasing urine output. Together, they provide effective and complementary blood pressure control, reducing the risk of cardiovascular events such as stroke and heart attack. This combination is ideal for patients who require more than one agent for optimal blood pressure management.
Tags:
- Dual mechanism for enhanced blood pressure control
- Reduces risk of stroke, heart attack, and kidney disease
- Convenient once-daily dosing improves compliance
- Helps control fluid retention and vascular resistance
- Suitable for patients needing combination therapy
Usage Information
Dosage
Take one tablet once daily, with or without food Swallow whole; follow doctor’s instructions carefully Monitor blood pressure and kidney function regularly Avoid sudden discontinuation without medical advice
Side Effects
Common: dizziness, headache, increased urination, fatigue Possible: electrolyte imbalance (low potassium), dehydration Rare: severe allergic reactions, angioedema Seek medical help if swelling, rash, or breathing difficulties occur
Contraindications
Hypersensitivity to Olmesartan, Hydrochlorothiazide, or sulfonamides Anuria or severe kidney impairment Pregnancy and breastfeeding (consult doctor) Severe liver disease Use with aliskiren in diabetes or kidney impairment